KFDA nods PACran cranberry powder health claim

Published: 2009-12-18 06:56:00

Updated: 2009-12-18 06:56:00

Decas Botanical Synergies (DBS), manufacturer of PACran, the first clinically supported and proanthocyanidin (PAC) standardized cranberry powder, has obtained Korean Food and Drug Administration (KFDA) approval for a health claim supporting urinary health, according to the Korea Cranberry Marketi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK